Recalls / Active ingredient / Tranexamic Acid
Tranexamic Acid
5 FDA drug recalls involving the active ingredient “Tranexamic Acid” — 1 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-06-13 | Class III | Tranexamic Acid USP Tablets, 650 mg, 30 tablets (3X10) Unit Dose, Rx Only, Manufactured for: AvKARE Pulaski, T | AVKARE LLC |
| 2023-06-12 | Class III | Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharma | Amring Pharmaceuticals Inc |
| 2022-09-26 | Class III | Tranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by: | AuroMedics Pharma LLC |
| 2020-08-17 | Class I | Tranexamic Acid Injection, USP, 1000 mg/10 mL (100 mg/mL), 10 mL Single-Dose Vial (NDC 67457-197-00); 10 x 10 | Mylan Institutional LLC |
| 2013-10-31 | Class II | Tranexamic Acid Injection USP, 1000mg/10mL, 10mL vial, Rx only. Mfd by: Fresenius Kabi USA, LLC Packaged un | Fresenius Kabi USA, LLC |